Related Experiment Video
Updated: Jul 13, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Fatal neurological disease in scrapie-infected mice induced for experimental autoimmune encephalomyelitis
Yael Friedman-Levi1, Haim Ovadia, Romana Hoftberger
1Department of Neurology, Hadassah University Hospital, Jerusalem, Israel.
Abstract:
During the years or decades of prion disease incubation, at-risk individuals are certain to encounter diverse pathological insults, such as viral and bacterial infections, autoimmune diseases, or inflammatory processes. Whether prion disease incubation time and clinical signs or otherwise the pathology of intercurrent diseases can be affected by the coinfection process is unknown. To investigate this possibility, mice infected with the scrapie agent at both high and low titers were subsequently induced for experimental autoimmune encephalomyelitis, an immune system-mediated model of central nervous system (CNS) inflammation. We show here that co-induced mice died from a progressive neurological disease long before control mice succumbed to classical scrapie. To investigate the mechanism of the co-induced syndrome, we evaluated biochemical and pathological markers of both diseases. Brain and spleen PrP(Sc) levels in the dying co-induced mice were comparable to those observed in asymptomatic scrapie-infected animals, suggesting that co-induced disease is not an accelerated form of scrapie. In contrast, inflammatory markers, such as demyelination, immune cell infiltrates, and gliosis, were markedly increased in co-induced mouse spinal cords. Activated astrocytes were especially elevated in the medulla oblongata. Furthermore, PrP(sc) depositions were found in demyelinated white matter areas in co-induced mouse spinal cords, suggesting the presence of activated infected immune cells that infiltrate into the CNS to facilitate the process of prion neuroinvasion. We hypothesize that inflammatory processes affecting the CNS may have severe clinical implications in subjects incubating prion diseases.
Insights
Inflammation during prion disease incubation accelerates neurological decline. Co-infection with autoimmune conditions significantly shortens survival, highlighting the clinical impact of central nervous system inflammation in prion diseases.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Prion diseases have long incubation periods where individuals may experience other health issues.
- The impact of concurrent infections or inflammatory conditions on prion disease progression is unknown.
Purpose of the Study:
- To investigate how experimental autoimmune encephalomyelitis (EAE), a model of CNS inflammation, affects scrapie prion disease progression in mice.
- To elucidate the mechanisms underlying any observed changes in disease course.
Main Methods:
- Mice were infected with the scrapie agent and subsequently induced with EAE.
- Biochemical and pathological markers of both prion disease and EAE were analyzed.
- Prion protein (PrPSc) levels, inflammatory markers (demyelination, gliosis, immune cell infiltration), and PrPSc deposition were evaluated.
Main Results:
- Mice co-induced with EAE died significantly earlier than control scrapie-infected mice.
- PrPSc levels in the brain and spleen were similar to asymptomatic scrapie-infected mice, indicating the co-induced disease was not accelerated scrapie.
- Markedly increased inflammatory markers, including demyelination and gliosis, were observed in the spinal cords of co-induced mice.
- PrPSc depositions were found in demyelinated areas, suggesting prion neuroinvasion facilitated by infiltrating immune cells.
Conclusions:
- Inflammatory processes, particularly within the central nervous system, can severely impact individuals incubating prion diseases.
- Concurrent inflammation may not accelerate prion replication but can lead to a more rapid and severe clinical presentation.
- These findings suggest a critical interplay between the immune system and prion pathogenesis.

